Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Category
Global or ExUS Equities - Industry Sector
Sponsor
Global X
Fund Family
Index
Solactive Genomics Index
Index Weighting
Active/Passive
Expense
0.50%
Inverse/Leveraged
IPO
Apr 10, 2019
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
2.90%
SMA50
4.04%
SMA200
29.52%
Return% 1Y
61.24%
Return% 3Y
25.24%
Return% 5Y
-3.98%
Return% 10Y
Return% SI
Flows% 1M
10.57%
Flows% 3M
10.16%
Flows% YTD
33.80%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
52
AUM
112.92M
NAV/sh
52W High
74.19 -6.17%
52W Low
41.16 69.12%
Volatility
3.28% 3.51%
ATR (14)
2.35
RSI (14)
54.58
Beta
1.22
Rel Volume
0.00
Avg Volume
33.86K
Volume
0
Perf Week
6.15%
Perf Month
1.21%
Perf Quarter
26.81%
Perf Half Y
53.27%
Perf YTD
53.14%
Perf Year
56.57%
Perf 3Y
95.98%
Perf 5Y
-18.79%
Perf 10Y
-
Prev Close
69.61
Price
69.61
Change %
0.00%
Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.